MedPath

ACCEL-LEFLUNOMIDE

ACCEL-LEFLUNOMIDE

Approved
DIN Number

02478862

Drug Class

Human

Market Date

Sep 19, 2019

Company
HC

accel pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02478862
AIG Number0140182001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AK01 LEFLUNOMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:24.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

LEFLUNOMIDEActive
Strength: 10 MG
Monograph: LEFLUNOMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.